A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study
Keisuke Seki, Takaaki Tamagawa, Hiroyasu Yasuda, Soichiro Manaka, Daisuke Akita, Atsushi Kamimoto, Yoshiyuki Hagiwara · 2024
Read A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study by Keisuke Seki, Takaaki Tamagawa, Hiroyasu Yasuda, Soichiro Manaka, Daisuke Akita, Atsushi Kamimoto, Yoshiyuki Hagiwara (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11538207.txt.
Description
Starting bone-protecting drugs after dental implants are already working is watched for harm in a 2024 cohort study by Keisuke Seki and co-authors. Rare cases of jaw bone death around implants have been linked to these medicines, and gum infection around an implant is a suspected trigger.
Ninety-four patients with 270 implants under maintenance care were split into drug starters and controls. Dentists tracked pocket depth and bleeding around implants, bone loss at the margin, and jaw cortex signs, from baseline to the last visit. Statistical models hunted risk factors for peri-implantitis. The study offers early evidence for a clinical bind: the drugs protect skeletons, but their effect on established implants was uncharted.
Catalog record
| CREATOR | Keisuke Seki, Takaaki Tamagawa, Hiroyasu Yasuda, Soichiro Manaka, Daisuke Akita, Atsushi Kamimoto, Yoshiyuki Hagiwara |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |